News
🇪🇺 EMALatest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 1–12 of 353 articles
Quick answer
NovaPharmaNews Europe & United Kingdom news feed tracks 353 published stories — EMA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
Chinese drugmakers struggle to recruit for EU
Eli Lilly to Acquire AtaiBeckley for $2.8B
EMA Emer Cooke speech at EP SANT panel
Zentalis Pharmaceuticals to Present at ESMO
EU/UK Regulator Round-up: 20 July 2026
EMA Backs Etcamah for ESR1+ Breast Cancer
Incyte Data to Be Highlighted in ESMO 2026 Madrid
EMA Review of Apitegromab in Spinal SMA Delayed
Regulating AI in drug discovery: EMA FDA ICH
Acadia Daybu CHMP OK for Rett syndrome
JASCAYD (nerandomilast) Wins EU Approval for IPF & PPF
Vanda: EMA Positive Opinion for Imsidolimab in GPP
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.